About DF/HCC

Dana-Farber/Harvard Cancer Center (DF/HCC), an NCI-designated comprehensive cancer center, was founded to integrate and build upon the collective talent and resources of the Harvard cancer research community. Five Boston academic medical institutions—Beth Israel Deaconess Medical Center, Boston Children’s Hospital, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Massachusetts General Hospital—and two Harvard Schools—the Harvard Medical School and the Harvard T.H. Chan School of Public Health—combined their scientific strengths to create a rich, collaborative environment that transcends institutional borders. DF/HCC is the powerful successor organization to the Dana-Farber Cancer Institute Comprehensive Cancer Center, one of the original cancer centers designated by the NCI in 1973.

Today, more than 1,100 DF/HCC cancer researchers are working together in innovative clinical-, translational-, basic-, and population-based research programs. Our members receive in excess of $600 million in cancer research funding. Cost-effective shared facilities, or centralized core laboratories, enable access to cutting edge technologies and allow us to build world-class scientific archives. Our members are training and educating the next generation of cancer researchers. Thousands of patients are being enrolled in our clinical trials. 

As one of the largest cancer research enterprises in the world, DF/HCC is committed to maximizing the impact of its research for cancer patients and ultimately realizing a world without cancer.

Breast Cancer

Cancer Care Delivery Research

Cancer Cell Biology

Cancer Data Sciences

Cancer Epidemiology

Cancer Genetics and Epigenetics

Cancer Immunology

Cancer Risk, Prevention, and Early Detection

Developmental Therapeutics

Gastrointestinal Malignancies

Gynecologic Cancers

Kidney Cancer

Leukemia

Lung Cancer

Lymphoma and Myeloma

Melanoma

Neuro-Oncology

Prostate Cancer

Administration

Drew Memmott

 Associate Director for Administration (617) 632-3488 EMAIL
Amanda Smith Executive Assistant to Drew Memmott (617) 632-3487 EMAIL
Rachel Wallen DF/HCC Administrative Specialist (617) 632-6198 EMAIL


Communications
Richard Oakley Communications Director (617) 632-4276 EMAIL


Core Facilities
Michelle Cox Senior Director for Core Facilities (617) 632-3566 EMAIL
Rachel Goldblatt Program Manager (617) 632-2587 EMAIL


Informatics    
Thomas Leonard Web Systems Architect (617) 632-3937 EMAIL


Initiative to Eliminate Cancer Disparities
Karen Burns White Deputy Associate Director (617) 632-3244 EMAIL
Brittany Michel Program Manager   EMAIL


Membership, Program Coordination, and Operations
Deborah Goff Deputy Associate Director for Program and Operations Support (617) 632-4044 EMAIL
Jackie Hwang Program Manager (617) 632-5685 EMAIL
Erica Fletcher Grant Administrator (617) 632-4864 EMAIL


For clinical trials administration contact information, visit the Clinical Research section.

Ways of Giving

Find out more about how to support the Cancer Center:
Rebecca Gavin
DF/HCC Development Office
10 Brookline Place, West, 6th Floor
Brookline, MA 02445
(617) 632-3491
RGavin@partners.org

Contact Us

DF/HCC Central Administration 
450 Brookline Avenue, BP332A
Boston, MA 02215

(617) 632-2100
(877) 420-3951 Toll Free
(617) 632-4452 Fax
DFHCC@partners.org

Membership

Join more than 1,100 other cancer researchers across the Harvard community and become a member of DF/HCC. Benefits include access to our shared resources at reduced rates.